Mckesson Sugar Free Cough Suppressant Oral Anesthetic Lozenge
NDC Package 68599-1090-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mckesson Sugar Free Cough Suppressant Oral Anesthetic (menthol lozenge) lozenges is usesTemporarily relievescough as may occur with a cold or inhaled irritantsoccasional minor irritation and sore throat. This formulation utilizes a lozenge delivery system. Marketed by Mckesson Medical-surgical, this product is identified by NDC 68599-1090 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
68599-1090-3
Package Description
300 LOZENGE in 1 BOX
Product Code
68599-1090
11-Digit Billing Format
68599109003
RxNorm Crosswalk
RxCUI: 476973 - menthol 5.8 MG Oral Lozenge

Clinical Specifications

Proprietary Name
Mckesson Sugar Free Cough Suppressant Oral Anesthetic
Non-Proprietary Name
Menthol Lozenge
Substance Name
Menthol, Unspecified Form
Dosage Form
Lozenge - A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
MENTHOL, UNSPECIFIED FORM 5.8 mg/1
Usage Information
UsesTemporarily relievescough as may occur with a cold or inhaled irritantsoccasional minor irritation and sore throat

Regulatory & Marketing

Labeler Name
Mckesson Medical-surgical
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68599-1090-3 identifies a specific commercial package of 300 lozenge in 1 box of Mckesson Sugar Free Cough Suppressant Oral Anesthetic, a human over the counter drug labeled by Mckesson Medical-surgical. This lozenge is formulated for oral use and contains menthol, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson Medical-surgical on September 01, 2022. The current certification is valid through December 31, 2026.

How is this Mckesson Medical-surgical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68599109003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68599-1090-3
11-Digit CMS (5-4-2)
68599-1090-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.